ARTICLE | Distillery Therapeutics
Therapeutics: Interleukin-2 (IL-2)
May 7, 2015 7:00 AM UTC
Mouse studies suggest an IL-2 fusion protein could help treat cancer by boosting the efficacy of tumor-targeting mAbs. Mouse IL-2 was fused to the Fc domain of mouse immunoglobulin G2a (IgG2a) to exte...